AU’s TGA adds safety warning on BMS’ Yervoy® (ipilimumab)

Australia’s TGA provided a safety update for BMS’ Yervoy® (ipilimumab), resulting in a warning on the PI that ipilimumab has been linked to serous retinal detachment, a rare but serious adverse event.